Clinical Trials Browser

Phase 1/2 × Vorinostat × Plasma cell × Clear all

NCT01297764 2026-02-19

QUAD

Phase 1/2 Active not recruiting

Multiple Myeloma

NCT01502085 2022-01-21

RZD

Phase 1/2 Completed

25 enrolled 5 charts

Multiple Myeloma

NCT00857324 2017-09-06

Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients

Phase 1/2 Terminated

Multiple Myeloma